phase3 recommended cpct treatment clinical biotechs volunteers adults data aiims rules booster company regulatory indigenous hepatitis rare children coronavirus market syrup manufacture uk phase mg disease heart conduct emergency total

Articles for Dcgi, search results for hepatitis

Houston COVID-19 vaccine Corbevax gets DCGI approval for use in India
2 years, 11 months ago

Houston COVID-19 vaccine Corbevax gets DCGI approval for use in India

Firstpost  

The vaccine uses an older recombinant protein yeast fermentation technology similar to that used for the recombinant hepatitis B vaccine which has been around for 40 years. Our vaccine technology offers a path to address an unfolding humanitarian crisis, namely the vulnerability the low- and middle-income countries face against the delta variant,” said Dr Peter Hotez, professor and dean of …

Technology World Houston Covid Vaccine 40 Years Tch
Zydus announces prices for its Covid drug Virafin approved by DCGI for use in moderate cases
3 years, 7 months ago

Zydus announces prices for its Covid drug Virafin approved by DCGI for use in moderate cases

India Today  

Drug Firm Zydus Cadila has set the price of its medicine ‘Virafin' at Rs 11,995 per dose. After the DCGI's approval for use of this medicine in the treatment of moderate cases of Covid-19, the pharma giant has begun dispatching doses to its vendors. 'Virafin,' a single-use medication obtained emergency use clearance from the Drug Controller General of India, the …

India Covid Drug Dcgi Zydus Zydus Cadila Virafin
Zydus Cadila Seeks DCGI Nod for Use of Hepatitis Drug for Covid-19 Treatment
3 years, 8 months ago

Zydus Cadila Seeks DCGI Nod for Use of Hepatitis Drug for Covid-19 Treatment

News 18  

Drug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General of India for additional indication of its hepatitis drug Pegylated Interferon Alpha-2b for treating COVID-19. Phase-III clinical trials with Pegylated Interferon Alpha 2b, which company sells under the brand name 'PegiHep' has shown promising results in treating COVID-19, Zydus Cadila said …

India Drug Dcgi Alpha Interferon Zydus Cadila Cadila
Zydus Cadila seeks DCGI nod for use of hepatitis drug in Covid-19 treatment
3 years, 8 months ago

Zydus Cadila seeks DCGI nod for use of hepatitis drug in Covid-19 treatment

India Today  

Zydus Cadila on Monday said it had sought approval from the Drugs Controller General of India for use of its viral hepatitis drug in treating Covid-19 after its Phase 3 clinical trials showed promising results. The drug reduced the duration for supplemental oxygen to 56 hours from 84 hours in moderate Covid-19 patients, Zydus Cadila said in a statement. “With …

Patients Drug Dcgi Phase 3 Zydus Zydus Cadila Cadila
Zydus Cadila gets DCGI nod for Phase 3 trial of repurposed drug to treat Covid-19
4 years ago

Zydus Cadila gets DCGI nod for Phase 3 trial of repurposed drug to treat Covid-19

India Today  

Gujarat-based drug manufacturer Zydus Cadila today said it has received approval from the Drugs Controller General of India to conduct Phase 3 clinical trials on its re-purposed drug that it hopes to use for Covid-19 treatment. The drug, Pegylated Interferon alpha-2b, 'PegiHepTM', is an approved drug that been in use since 2001 and is now being re-purposed to treat Covid-19 …

India Trial Trials Patients Drug Phase Clinical
Subject Expert Committee seeks DCGI nod to use hepatitis injection in phase 3 trial of COVID-19 vaccine
4 years, 4 months ago

Subject Expert Committee seeks DCGI nod to use hepatitis injection in phase 3 trial of COVID-19 vaccine

Firstpost  

So far, Thymosin @-1 injection 1.6 mg has been used to treat chronic Hepatitis B New Delhi: The Subject Expert Committee at the Central Drugs Standard Control Organisation has recommended that the country’s top drug regulator grant permission for phase 3 clinical trial using Thymosin @-1 injection 1.6 mg on moderate to severe COVID-19 patients, said a senior health ministry …

Injection Dcgi Thymosin